Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.96 |
| ▸ | PPARG | P37231 | 6/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.96 |
| ▸ | RXRA | P19793 | 2/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.74 |
| ▸ | PPARA | Q07869 | 5/20 | 0.74 |
| ▸ | F7 | P08709 | 4/20 | 0.74 |
| ▸ | F3 | P13726 | 4/20 | 0.74 |
| ▸ | PPARD | Q03181 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL276082 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL3221528 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL29225 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL116899 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL117314 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL16269975 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL742417 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL16232222 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL742418 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL3221804 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350557-A1 | FREE FATTY ACIDS AND METHODS OF MANUFACTURE AND USE FOR TREATING CORONAVIRUS AND OTHER VIRAL RESPIRATORY INFECTIONS | LIPID PHARMACEUTICALS EHF (IS) | 2024-10-24 | — | — | US | claimed |
| US-12064455-B2 | Free fatty acids and methods of manufacture and use for treating coronavirus and other viral respiratory infections | LIPID PHARMACEUTICALS EHF (IS) | 2024-08-20 | — | — | US | claimed |
| US-20210290692-A1 | FREE FATTY ACIDS AND METHODS OF MANUFACTURE AND USE FOR TREATING CORONAVIRUS AND OTHER VIRAL RESPIRATORY INFECTIONS | LIPID PHARMACEUTICALS EHF (IS) | 2021-09-23 | — | — | US | claimed |
| WO-2021186248-A1 | FREE FATTY ACIDS AND METHODS OF MANUFACTURE AND USE FOR TREATING CORONAVIRUS AND OTHER VIRAL RESPIRATORY INFECTIONS | LIPID PHARMACEUTICALS EHF (IS) | 2021-09-23 | — | — | WO | claimed |
| US-10314789-B2 | Soft gelatin encapsulated pharmaceutical composition of cis-5,8,11,14,17-eicosapentaenoic acid in free acid form and cis-7,10,13,16,19-docosapentaenoic acid in free acid form | CHRYSALIS PHARMA AG (CH) | 2019-06-11 | — | — | US | claimed |
| US-20190167599-A1 | SOFT GELATIN ENCAPSULATED PHARMACEUTICAL COMPOSITION OF CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID IN FREE ACID FORM AND CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID IN FREE ACID FORM | CHRYSALIS PHARMA AG (CH) | 2019-06-06 | — | — | US | claimed |
| US-10117844-B2 | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | OMTHERA PHARMACEUTICALS, INC. (US) | 2018-11-06 | — | — | US | claimed |
| EP-2383251-B1 | Co-precipitated salts of fatty acids | JOST CHEMICAL CO (US) | 2018-05-09 | — | — | EP | claimed |
| US-9492545-B2 | Compositions of statins and omega-3 fatty acids | OMTHERA PHARMACEUTICALS INC. (US) | 2016-11-15 | — | — | US | claimed |
| CN-105358190-A | Adhesion preventing agent | FARNEX INC | 2016-02-24 | — | — | CN | claimed |
| US-20110237813-A1 | CO-PRECIPITATED SALTS OF FATTY ACIDS | JOST CHEMICAL CO. (US) | 2011-09-29 | — | — | US | claimed |
| EP-2349250-A1 | FATTY ACIDS FOR USE AS A MEDICAMENT | Lipid Pharmaceuticals Ehf. (IS) | 2011-08-03 | — | — | EP | claimed |
| WO-2010049954-A1 | FATTY ACIDS FOR USE AS A MEDICAMENT | LIPID PHARMACEUTICALS EHF. (IS) | 2010-05-06 | — | — | WO | claimed |
| CN-101123879-A | Methods for treatment of angiogenesis | UNIV JOHNS HOPKINS (US) | 2008-02-13 | — | — | CN | claimed |
| US-20060088574-A1 | Nutritional supplements | WACHOVIA BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2006-04-27 | — | — | US | claimed |
| US-20050272529-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-12-08 | — | — | US | claimed |
| US-20040220376-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-20040220371-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-20040220375-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-4950656-A | WITH TRIGLYCERIDES AND/OR STEROLS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-08-21 | — | — | US | claimed |